载脂蛋白A-I与高密度脂蛋白：这会是无创血管成形术时代的开端吗？ - Suppr | 超能文献

Apolipoprotein A-I and high-density lipoprotein: is this the beginning of the era of noninvasive angioplasty?

作者信息

Ballantyne Christie M, Nambi Vijay

出版信息

J Am Coll Cardiol. 2004 Oct 6;44(7):1436-8. doi: 10.1016/j.jacc.2004.07.018.

DOI:10.1016/j.jacc.2004.07.018

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Apolipoprotein A-I and high-density lipoprotein: is this the beginning of the era of noninvasive angioplasty?载脂蛋白A-I与高密度脂蛋白：这会是无创血管成形术时代的开端吗？

J Am Coll Cardiol. 2004 Oct 6;44(7):1436-8. doi: 10.1016/j.jacc.2004.07.018.

2

Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.载脂蛋白B、载脂蛋白AI与早发性冠状动脉疾病的遗传学

J Intern Med. 2006 May;259(5):473-80. doi: 10.1111/j.1365-2796.2006.01645.x.

3

Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.胆固醇酯转运蛋白、过氧化物酶体增殖物激活受体α、载脂蛋白E及载脂蛋白A-I基因多态性对高密度脂蛋白胆固醇、载脂蛋白A-I、脂蛋白A-I及脂蛋白A-I:A-II浓度的影响：心肌梗死前瞻性流行病学研究

Metabolism. 2009 Mar;58(3):283-9. doi: 10.1016/j.metabol.2008.09.026.

4

Raising high-density lipoprotein cholesterol: innovative strategies against an old adversary.提高高密度脂蛋白胆固醇：对抗老对手的创新策略。

Curr Atheroscler Rep. 2005 Mar;7(2):88-94. doi: 10.1007/s11883-005-0029-x.

5

High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein.高密度脂蛋白模拟物：聚焦于合成高密度脂蛋白

Am J Cardiol. 2007 Dec 3;100(11 A):S62-7. doi: 10.1016/j.amjcard.2007.09.081.

6

Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.低高密度脂蛋白胆固醇与心血管疾病：他汀类药物治疗降低风险

Am Heart J. 2006 Mar;151(3):556-63. doi: 10.1016/j.ahj.2005.03.049.

7

Apolipoproteins as markers and managers of coronary risk.载脂蛋白作为冠状动脉风险的标志物和调控因子。

QJM. 2006 May;99(5):277-87. doi: 10.1093/qjmed/hcl027. Epub 2006 Feb 27.

8

[Apolipoprotein A-I can be a new tool in the treatment of atherosclerosis].载脂蛋白A-I可成为治疗动脉粥样硬化的新工具。

Lakartidningen. 2004 Mar 25;101(13):1196-7.

9

High density lipoprotein cholesterol in coronary artery patients: is it as low as expected?冠状动脉疾病患者的高密度脂蛋白胆固醇：是否如预期的那样低？

Anadolu Kardiyol Derg. 2006 Mar;6(1):92-3; author reply 93.

10

ETC-216 for coronary artery disease.依替巴肽用于治疗冠状动脉疾病。

Expert Opin Biol Ther. 2011 Mar;11(3):387-94. doi: 10.1517/14712598.2011.557061. Epub 2011 Jan 28.

引用本文的文献

1

Urinary Proteomic Profile of Arterial Stiffness Is Associated With Mortality and Cardiovascular Outcomes.尿蛋白质组谱与动脉僵硬度相关，与死亡率和心血管结局相关。

J Am Heart Assoc. 2022 Apr 19;11(8):e024769. doi: 10.1161/JAHA.121.024769. Epub 2022 Apr 12.

2

The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.常见的载脂蛋白A-1基因多态性-75A>G与急性心肌梗死后恢复过程中复发性冠状动脉事件的种族差异有关。

Heart Int. 2009 Jun 30;4(1):e8. doi: 10.4081/hi.2009.e8.